Abinand Rangesh insider trades: Tecogen (TGEN) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Abinand reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 20, 2026 | TGEN | ↑ Buy | 3,000 | $2.30 | $7K | Direct | Mar 23, 2026 (3d) |
| Aug 30, 2023 | TGEN | ↑ Buy | 1,001 | $1.02 | $1K | Direct | Sep 1, 2023 (2d) |
| Jun 20, 2023 | TGEN | ↑ Buy | 1,500 | $1.04 | $2K | Direct | Jun 20, 2023 (0d) |
| Mar 20, 2023 | TGEN | ↑ Buy | 1,800 | $0.88 | $2K | Direct | Mar 27, 2023 (7d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other TGEN insiders
Open-market trades in the last 12 months
About Abinand Rangesh's insider trades
Abinand Rangesh is Chief Executive Officer at Tecogen (TGEN). Since Mar 20, 2023, Abinand has reported 4 open-market purchases worth $11K and no sales on SEC Form 4. In the last 12 months: 1 buy ($7K).
Their filings also include grants and awards (4 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TGEN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.